Editorial Board — Medscape Ob/Gyn & Women's Health

Board Members

 

Board Member Details

Peter S. Bernstein, MD, MPH
Peter S. Bernstein, MD, MPH

Professor of Clinical Obstetrics & Gynecology and Women's Health, Department of Obstetrics & Gynecology and Women's Health, Albert Einstein College of Medicine, New York, New York; Director of Maternal-Fetal Medicine Fellowship Program, Department of Obstetrics & Gynecology and Women's Health, Jack D. Weiler Hospital of Montefiore Medical Center, Bronx, New York

Peter S. Bernstein, MD, MPH, has disclosed no relevant financial relationships.

[ Back to Top ]
Linda D. Bradley, MD
Linda D. Bradley, MD

Vice Chair, Department of OB/GYN, Women's Health Institute; Director, Menstrual Disorders, Fibroids & Hysteroscopic Services, Cleveland Clinic, Cleveland, Ohio

Linda D. Bradley, MD, has disclosed the following relevant financial relationships:
Served as a speaker or member of a speakers bureau for: TevaPharmaceuticals USA; Ferring Pharmaceuticals; Bayer HealthCare Pharmaceuticals

[ Back to Top ]
Beth A. Jordan, MD
Beth A. Jordan, MD

Medical Director, Association of Reproductive Health Professionals, Washington, DC

Beth A. Jordan, MD, has disclosed no relevant financial relationships.

[ Back to Top ]
Andrew Kaunitz, MD
Andrew Kaunitz, MD

Professor and Associate Chair, Department of Obstetrics and Gynecology, University of Florida College of Medicine, Jacksonville

Andrew Kaunitz, MD, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for (consultant only): Bayer HealthCare Pharmaceuticals; Teva Pharmaceuticals USA; Merck & Co., Inc.
Received research grant from: Bayer HealthCare Pharmaceuticals; Teva Pharmaceuticals USA; Agile; Medical Diagnostic Laboratories; Noven Pharmaceuticals, Inc.
Received income in an amount equal to or greater than $250 from: Bayer HealthCare Pharmaceuticals; Merck & Co., Inc.; Teva Pharmaceuticals USA
Owns stocks from: Becton, Dickinson and Company

[ Back to Top ]
Peter Kovacs, MD, PhD
Peter Kovacs, MD, PhD

Medical Director, Kaali Institute IVF Center, Budapest, Hungary

Peter Kovacs, MD, PhD, has disclosed no relevant financial relationships.

[ Back to Top ]
E. Michael Lewiecki, MD
E. Michael Lewiecki, MD

Clinical Assistant Professor of Medicine, University of New Mexico School of Medicine; Director, New Mexico Clinical Research and Osteoporosis Center, Albuquerque, New Mexico

E. Michael Lewiecki, MD, has disclosed the following relevant financial relationships:
Received grant and research support from: Amgen Inc.; Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Merck & Co., Inc.; Warner-Chilcott; Genentech, Inc.
Served on the scientific advisory board for: Amgen Inc.; Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Genentech, Inc.; Merck & Co., Inc.
Served as a speaker or member of a speakers bureau for: Amgen Inc.; Eli Lilly and Company; Novartis Pharmaceuticals Corporation; Genentech, Inc.
Board of Directors: International Society for Clinical Densitometry

[ Back to Top ]
JoAnn E. Manson, MD, DrPH
JoAnn E. Manson, MD, DrPH

Professor of Medicine, Elizabeth Fay Brigham Professor of Women's Health, Harvard Medical School; Chief, Division of Preventive Medicine, Brigham and Women's Hospital, Boston, Massachusetts; President-Elect, North American Menopause Society, Mayfield Heights, Ohio

JoAnn E. Manson, MD, DrPH, has disclosed no relevant financial relationships.

[ Back to Top ]
Susan J. Wysocki, RNC, NP, WHNP-BC
Susan J. Wysocki, RNC, NP, WHNP-BC

President and CEO, National Association of Nurse Practitioners in Women's Health, Washington, DC

Susan J. Wysocki, RNC, NP, WHNP-BC, has disclosed the following relevant financial relationships:
Served as a director, officer, partner, employee, advisor, consultant, or trustee for: Bayer HealthCare Pharmaceuticals; Teva Pharmaceuticals USA; Upsher-Smith; Novo Nordisk; GlaxoSmithKline; Church and Dwight; Watson Pharmaceuticals, Inc.; Azur Pharma
Served as a speaker or member of a speakers bureau for: Bayer HealthCare Pharmaceuticals; Teva Pharmaceuticals USA; Novo Nordisk
Received income in an amount greater than or equal to $250 from: Bayer HealthCare Pharmaceuticals; Teva Pharmaceuticals USA; Upsher-Smith; Novo Nordisk; GlaxoSmithKline; Church and Dwight; Watson Pharmaceuticals, Inc.; Azur Pharma

[ Back to Top ]
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.